Literature DB >> 30561705

Cost-Effective But Unaffordable: The CAR-T Conundrum.

Ashley A Leech1, Stacie B Dusetzina1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30561705     DOI： 10.1093/jnci/djy195

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices.

Authors:  Shellie D Ellis; Mugur Geana; Christine B Mackay; Deborah J Moon; Jessie Gills; Andrew Zganjar; Gayle Brekke; J Brantley Thrasher; Tomas L Griebling
Journal:  Urol Oncol       Date:  2019-03-29       Impact factor: 3.498

Review 2.  Are Biosimilars the Future of Oncology and Haematology?

Authors:  Pier Luigi Zinzani; Martin Dreyling; William Gradishar; Marc Andre; Francisco J Esteva; Suliman Boulos; Eva González Barca; Giuseppe Curigliano
Journal:  Drugs       Date:  2019-10       Impact factor: 9.546

3.  Critical Reflections on Reimbursement and Access of Advanced Therapies.

Authors:  Steven Simoens; Katrien De Groote; Cornelis Boersma
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

4.  Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.

Authors:  Rositsa Koleva-Kolarova; James Buchanan; Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; Maureen Rutten-van Mölken; László Szilberhorn; Tamás Zelei; Balázs Nagy; Sarah Wordsworth; Apostolos Tsiachristas
Journal:  Appl Health Econ Health Policy       Date:  2022-04-04       Impact factor: 3.686
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.